Financial services firms face constant pressure from regulation, technology, and competition, and leaders can’t afford to spend resources on the wrong priorities. Learn how the Threat and Opportunity Prioritization Matrix helps teams rank external signals by impact, probability, and confidence so they can act on what matters most.
Pricing power isn’t a number on a product sheet. It’s a system, and the companies that have it connect price realization, competitor intelligence, deal governance, pricing models, and continuous monitoring into one disciplined operating model.
At Pharma CI USA 2026, AI came up in nearly every conversation, but the bigger story was what leadership now expects from competitive intelligence. Here are the key takeaways on trust in AI, the rising value of primary intelligence, and why CI’s impact is increasingly measured by the decisions it shapes.
AI adoption in life sciences competitive intelligence nearly doubled in a single year. Our 2026 survey data shows where AI is delivering real impact, where friction is growing, and what CI leaders should realistically expect from their investment.
Most companies still treat benchmarking as an annual exercise, comparing last year’s numbers against a target that has already moved. The leaders are building continuous benchmarking engines that turn performance data into a live feed, so they can spot issues, adjust strategy, and compound small gains before competitors notice.
Sales leaders don’t lack competitive information, they lack a system for capturing the intelligence that already exists in every rep conversation. This piece breaks down how field signal, if collected continuously, becomes a strategic asset rather than an anecdote traded at the next sales meeting.
Sales battlecards are built once and go stale fast, leaving reps to repeat outdated claims a buyer has already heard corrected. This guide breaks down what it takes to replace a static enablement program with a continuous system: sourcing field intelligence, validating it, and delivering it to reps before their next competitive deal.
Every competitive strategy has blind spots, but the organizations that identify them first gain a lasting advantage. Learn the most common sources of strategic risk and how continuous competitive monitoring can help uncover emerging threats before they impact growth, revenue, and market position.
Your sales, service, and product teams see market shifts every day, but that knowledge rarely reaches leadership in a usable form. FieldForce captures, validates, and translates frontline insight into decision-ready intelligence, helping commercial leaders spot competitive threats earlier, uncover growth opportunities faster, and align teams around a shared view of the market.
Most pharma CI teams attend the major congresses. Few are structured to capture everything those congresses offer. This post breaks down the five most common intelligence gaps, and what a well-designed coverage program does to close them.
